Skip to main content

LeMaitre Vascular, Inc. (LMAT)

NASDAQ: LMAT · IEX Real-Time Price · USD
55.72 -0.02 (-0.04%)
Sep 24, 2021 4:00 PM EDT - Market closed
Market Cap1.21B
Revenue (ttm)150.52M
Net Income (ttm)28.77M
Shares Out20.61M
EPS (ttm)1.39
PE Ratio40.12
Forward PE36.90
Dividend$0.41 (0.74%)
Ex-Dividend DateAug 25, 2021
Volume190,217
Open55.52
Previous Close55.74
Day's Range54.93 - 55.96
52-Week Range30.93 - 64.37
Beta1.32
AnalystsBuy
Price Target66.14 (+18.7%)
Est. Earnings DateOct 28, 2021

About LMAT

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the ...

IndustryHealth Care Equipment & Supplies
IPO DateOct 19, 2006
CEOGeorge LeMaitre
Employees386
Stock ExchangeNASDAQ
Ticker SymbolLMAT
Full Company Profile

Financial Performance

In 2020, LMAT's revenue was $129.37 million, an increase of 10.35% compared to the previous year's $117.23 million. Earnings were $21.22 million, an increase of 18.32%.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is 66.14, which is an increase of 18.70% from the latest price.

Price Target
$66.14
(18.70% upside)
Analyst Consensus: Buy

News

LeMaitre Vascular to Participate at Upcoming Investor Conferences in September

BURLINGTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four virtual investor conferences in September.

3 weeks ago - GlobeNewsWire

LeMaitre to Present at Upcoming Investor Conferences

BURLINGTON, Mass., Aug. 06, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in August.

1 month ago - GlobeNewsWire

Is This Under-the-Radar Medical Device Company a Post-Earnings Buy?

LeMaitre Vascular's operating fundamentals and balance sheet suggest it's a buy, depending on your objectives.

1 month ago - The Motley Fool

LeMaitre Vascular (LMAT) Beats Q2 Earnings Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of 17.65% and -0.07%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

LeMaitre Q2 2021 Financial Results

BURLINGTON, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2021 results, announced an $0.11/share quarterly div...

1 month ago - GlobeNewsWire

Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think " Yes "

LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.

2 months ago - Zacks Investment Research

LeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021

BURLINGTON, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2021 financial results on Thursday, July 29, 2021, afte...

2 months ago - GlobeNewsWire

LeMaitre Vascular (LMAT) to Report Q2 Results: Wall Street Expects Earnings Growth

LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

LeMaitre Vascular Sees Better Than Expected Q2 Sales, Raises $55M Via Equity At 9% Discount

LeMaitre Vascular Inc (NASDAQ: LMAT) has announced preliminary Q2 2021 results and sees net sales of $40.7 million compared to an estimated $37.9 million, up 64%Y/Y on a reported basis and +35% organica...

2 months ago - Benzinga

LeMaitre Announces Pricing of Public Offering of Common Stock

BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritt...

2 months ago - GlobeNewsWire

LeMaitre Vascular Announces Proposed Public Offering of Common Stock

BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an und...

2 months ago - GlobeNewsWire

LeMaitre Provides Q2 2021 Update

BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced preliminary unaudited result...

2 months ago - GlobeNewsWire

Should Investors Consider This Expanding Healthcare Business After Its Massive Dividend Hike?

Did LeMaitre Vascular jeopardize its payout with its recent 16% dividend lift?

2 months ago - The Motley Fool

LeMaitre to Present at the Goldman Sachs Virtual Global Healthcare Conference

BURLINGTON, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Hea...

3 months ago - GlobeNewsWire

LeMaitre Regains Five CE Marks

BURLINGTON, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it received CE marks under the European Medical De...

4 months ago - GlobeNewsWire

LeMaitre to Present at the Jefferies Virtual Healthcare Conference

BURLINGTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Co...

4 months ago - GlobeNewsWire

LeMaitre Vascular (LMAT) Recently Broke Out Above the 20-Day Moving Average

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

4 months ago - Zacks Investment Research

LeMaitre Vascular (LMAT) Matches Q1 Earnings Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and 0.95%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Recap: LeMaitre Vascular Q1 Earnings

Shares of LeMaitre Vascular (NASDAQ:LMAT) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 75.00% over the past year to $0.28, which bea...

4 months ago - Benzinga

LeMaitre Q1 2021 Financial Results

BURLINGTON, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2021 results and announced an $0.11/share quarterly...

4 months ago - GlobeNewsWire

LeMaitre to Present at Upcoming Investor Conferences

BURLINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in May.

4 months ago - GlobeNewsWire

Bull Of The Day: LeMatire Vascular (LMAT)

Bull Of The Day: LeMatire Vascular (LMAT)

4 months ago - Zacks Investment Research

LeMaitre Vascular (LMAT) Earnings Expected to Grow: Should You Buy?

LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

LeMaitre Will Announce First Quarter 2021 Earnings Results on April 29, 2021

BURLINGTON, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2021 financial results on Thursday, April 29, 2021, aft...

5 months ago - GlobeNewsWire

4 Critical Care Device Stocks to Deflect the COVID-19 Curveball

Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.

Other symbols:HRCMASIRMD
5 months ago - Zacks Investment Research